During the past decade, Covington Orthopedic and Sports Medicine Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Covington Orthopedic and Sports Medicine Institute" are "Defect of Articular Cartilage" (1 trials), "Knee Osteoarthritis" (1 trials) and "Osteoarthritis, Knee" (1 trials). Many other conditions were trialed in "Covington Orthopedic and Sports Medicine Institute" in a lesser frequency.

Most popular intervention types in "Covington Orthopedic and Sports Medicine Institute" are "Device" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Celution Device" (1 trials), "Hyalofast" (1 trials), "Microfracture" (1 trials), "Placebo" (1 trials) and "Sham Comparator" (1 trials). Other intervention names were less common.

The vast majority of trials in "Covington Orthopedic and Sports Medicine Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Covington Orthopedic and Sports Medicine Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Covington Orthopedic and Sports Medicine Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Covington Orthopedic and Sports Medicine Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".